(Q47247270)

12 January 2018

title

Neuropathology provides clues to the pathophysiology of Gaucher disease. (English)

1 reference

12 January 2018

1 reference

1 reference

Kondi Wong

1

1 reference

12 January 2018

Ellen Sidransky

2

1 reference

12 January 2018

Ajay Verma

3

1 reference

12 January 2018

Tonghui Mixon

4

1 reference

12 January 2018

Glenn D Sandberg

5

1 reference

12 January 2018

Laura K Wakefield

6

1 reference

12 January 2018

Alan Morrison

7

1 reference

12 January 2018

Alicia Lwin

8

1 reference

12 January 2018

Carlos Colegial

9

1 reference

12 January 2018

John M Allman

10

1 reference

12 January 2018

Raphael Schiffmann

11

1 reference

12 January 2018

publication date

1 July 2004

1 reference

12 January 2018

Molecular Genetics and Metabolism

published in

1 reference

12 January 2018

volume

82

1 reference

12 January 2018

page(s)

192-207

1 reference

12 January 2018

issue

3

1 reference

12 January 2018

Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Mutations of glucocerebrosidase: discrimination of neurologic and non-neurologic phenotypes of Gaucher disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Determination of Gaucher's disease phenotypes with monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Gaucher's Disease: Neurologic Disorder in Adult Siblings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Management of neuronopathic Gaucher disease: a European consensus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

The neuropathology of infantile Gaucher's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Type 2 and type 3 Gaucher disease: a morphological and biochemical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Acute infantile Gaucher's disease in identical twins. An account of clinical and neuropathologic observations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Late-infantile Gaucher disease in a child with myoclonus and bulbar signs: neuropathological and neurochemical findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Neuropathology of the Norrbottnian type of Gaucher disease. Morphological and biochemical studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Reactions of vessel walls and brain parenchyma to the accumulation of Gaucher cells in the Norrbottnian type (type III) of Gaucher disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Familial Psychosis and Diverse Neurologic Abnormalities in Adult-Onset Gaucher's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Central nervous system involvement in adult-onset Gaucher's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Neurological involvement in type 1 (adult) Gaucher's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Occurrence of Parkinson's syndrome in type I Gaucher disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Parkinson's syndrome preceding clinical manifestation of Gaucher's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Gaucher disease associated with parkinsonism: four further case reports

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Gaucher disease and parkinsonism: a phenotypic and genotypic characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Cree leukoencephalopathy and CACH/VWM disease are allelic at the EIF2B5 locus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Monoclonal antibodies against human beta-glucocerebrosidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Calcium pools mobilized by calcium or inositol 1,4,5-trisphosphate are differentially localized in rat heart and brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Inositol trisphosphate and thapsigargin discriminate endoplasmic reticulum stores of calcium in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Rat brain endoplasmic reticulum calcium pools are anatomically and functionally segregated

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Glucosylceramide and glucosylsphingosine modulate calcium mobilization from brain microsomes via different mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Somatosensory evoked potentials as a marker of disease burden in type 3 Gaucher disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Distinctive neuropathology revealed by α-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Hippocampal lesions in the neuronal ceroid lipofuscinoses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Giant synaptic potential hypothesis for epileptiform activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Coactivation of Local Circuit NMDA Receptor Mediated epsps Induces Lasting Enhancement of Minimal Schaffer Collateral epsps in Slices of Rat Hippocampus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Columnar organization in the subiculum formed by axon branches originating from single CA1 pyramidal neurons in the rat hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Organization of CA1 projections to the subiculum: A PHA-L analysis in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Excitatory synaptic interactions between CA3 neurones in the guinea-pig hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Local synaptic circuits in rat hippocampus: interactions between pyramidal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

A quantitative analysis of the dendritic organization of pyramidal cells in the rat hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

The hippocampal CA3 network: an in vivo intracellular labeling study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Multiple modes of neuronal population activity emerge after modifying specific synapses in a model of the CA3 region of the hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

The synaptic nature of the paroxysmal depolarizing shift in hippocampal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Localization of an endoplasmic reticulum calcium ATPase mRNA in rat brain by in situ hybridization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Elevation of intracellular glucosylceramide levels results in an increase in endoplasmic reticulum density and in functional calcium stores in cultured neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Intrinsic connections of macaque striate cortex: afferent and efferent connections of lamina 4C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Thalamic and other subcortical projections to area MT (visual area of superior temporal sulcus) in the marmoset Callithrix jacchus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Areal and laminar distribution of neurons interconnecting the central visual cortical areas 17, 18, 19, and MT in squirrel monkey (Saimiri)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Feedback connections from area MT of the squirrel monkey to areas V1 and V2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Topographically organized reciprocal connections between areas 17 and MT (visual area of superior temporal sulcus) in the marmoset Callithrix jacchus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Laminar organization of geniculocortical projections in Galago senegalensis and Aotus trivirgatus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Lysosphingolipids inhibit protein kinase C: implications for the sphingolipidoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Twenty five years of the "psychosine hypothesis": a personal perspective of its history and present status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Studies on the toxicity of 1-methyl-4-phenylpyridinium ion (MPP+) against mitochondria of mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Cytotoxicity of ventricular cerebrospinal fluid from Parkinson patients: correlation with clinical profiles and neurochemistry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Membrane binding and self-association of alpha-synucleins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

alpha-Synuclein membrane interactions and lipid specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Selective hippocampal neuron loss in dementia with Lewy bodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Selective neurofibrillary degeneration of the hippocampal CA2 sector is associated with four-repeat tauopathies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Specificity of human glucosylceramide beta-glucosidase towards synthetic glucosylsphingolipids inserted into liposomes. Kinetic studies in a detergent-free assay system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Factors affecting the binding of glucosylceramidase to its natural substrate dispersion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Solubilization of glucocerebrosidase from human placenta and demonstration of a phospholipid requirement for its catalytic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Activity of the phosphatidylcholine biosynthetic pathway modulates the distribution of fatty acids into glycerolipids in proliferating cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Phosphatidylcholine synthesis is elevated in neuronal models of Gaucher disease due to direct activation of CTP:phosphocholine cytidylyltransferase by glucosylceramide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.04.011

10.1016/J.YMGME.2004.04.011

7 January 2021

Identifiers

DOI

1 reference

12 January 2018

PubMed ID

15234332

1 reference

12 January 2018